Compare KR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KR | GEHC |
|---|---|---|
| Founded | 1883 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.9B | 29.1B |
| IPO Year | 2007 | 2022 |
| Metric | KR | GEHC |
|---|---|---|
| Price | $63.31 | $70.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 21 |
| Target Price | $68.32 | ★ $82.70 |
| AVG Volume (30 Days) | ★ 7.3M | 3.5M |
| Earning Date | 12-03-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.47% | 0.23% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | ★ 2.51 | 0.85 |
| Revenue | ★ $147,642,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $2.08 | $5.32 |
| Revenue Next Year | $1.31 | $4.60 |
| P/E Ratio | ★ $25.09 | $80.59 |
| Revenue Growth | 0.35 | ★ 4.84 |
| 52 Week Low | $54.15 | $58.75 |
| 52 Week High | $76.58 | $89.77 |
| Indicator | KR | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 63.16 | 65.22 |
| Support Level | $55.24 | $68.88 |
| Resistance Level | $65.11 | $72.77 |
| Average True Range (ATR) | 1.47 | 1.58 |
| MACD | 0.38 | 0.71 |
| Stochastic Oscillator | 82.60 | 94.01 |
Founded in 1883, Kroger is the largest pure-play supermarket operator in the United States, operating roughly 2,700 stores across more than 30 banners. Kroger's business is primarily grocery-led (roughly 79% of sales), spanning fresh food and private-label offerings, complemented by fuel centers (9%) and pharmacies (12%). The firm also generates income from advertising, data analytics, and manufacturing.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).